Semaglutide
What is Semaglutide?
Semaglutide is a synthetic peptide and GLP-1 receptor agonist, designed for weight loss and blood sugar regulation. It is widely researched and used clinically for managing obesity and type 2 diabetes.
How It Works (Mechanism of Action)
Semaglutide activates GLP-1 receptors, leading to increased insulin secretion, reduced glucagon levels, and slowed gastric emptying. This reduces appetite, improves glucose control, and promotes significant weight loss.
Potential Benefits & Use Cases
- Weight Loss: Promotes significant fat loss and appetite suppression.
- Blood Sugar Control: Improves glycemic control in type 2 diabetes.
- Metabolic Health: Enhances insulin sensitivity and reduces cardiovascular risk.
Typical Dosage & Administration
Administration: Subcutaneous injection.
Dosage:
- Typical doses range from 0.25 mg to 2.4 mg per week.
- Often administered once weekly, with gradual dose escalation.
Possible Side Effects
- Nausea: Common during initial use, typically subsides.
- Injection Site Reactions: Mild redness or irritation.
- Gastrointestinal Discomfort: Possible bloating or diarrhea.
Other Relevant Details
- Approved in many regions for weight management and diabetes treatment.
- May be combined with other weight loss peptides for enhanced effects.